Harrison's Practice
[Display All Sections]

Giant Cell Arteritis

Definition

  • A primary vasculitis syndrome characterized by inflammation of medium-sized and large arteries
    • Usually involves 1 or more cranial branches of the arteries originating from the aortic arch, particularly the temporal artery
    • Systemic large-vessel vasculitis of multiple arteries may also occur.
  • Classic presentation includes fever, anemia, high erythrocyte sedimentation rate (ESR), and headaches in a patient > 50 years of age.
    • Other common features include jaw claudication and muscular symptoms identical to those of polymyalgia rheumatica.
    • The most worrisome complication is permanent visual loss.
      • For this reason, giant cell arteritis must be considered a medical emergency.
  • Giant cell arteritis can manifest as 4 clinical phenotypes:
    • Cranial features (including headache, visual loss, jaw claudication)
    • Systemic inflammatory and constitutional symptoms
    • Polymyalgia rheumatica
      • Increasing evidence suggests that giant cell arteritis and polymyalgia rheumatica represent differing clinical spectrums of a single disease process.
    • Large vessel vasculitis
  • Also referred to as:
    • Temporal arteritis  
    • Cranial arteritis
    • Granulomatous arteritis  

Epidemiology

  • Incidence
    • Varies widely among different studies and geographic regions
    • In the U.S., annual rates (in persons ≥ 50 years) range from 6.9–32.8 per 100,000 persons.
  • Prevalence
    • 1–2 cases per 1000 in persons > 50 years
  • Age
    • Almost exclusively in persons > 50 years
    • Incidence increases with age.
  • Sex
    • Female-to-male ratio, 2–6:1
  • Race/ethnicity
    • Highest incidence in persons of Scandinavian descent
    • Rare in blacks

Risk Factors

  • Age
    • >50 years
    • 20 times more common in people 70–80 years of age than 50–60 years of age
  • Female sex
  • Genetic factors
    • HLA-DR4 allele expression
    • HLA -DRB1 alleles, especially HLA-DRB1*04

Etiology

  • Precise etiology is unknown.
  • Likely to be multifactorial
    • Genetic predisposition
    • Environmental exposures
    • Regulatory mechanisms associated with immune response to certain antigens
  • Lesions show an inflammatory infiltrate with lymphocytes and macrophages dominating.
  • HLA-DR4 predominance and local activation of T lymphocytes in the vasculitic lesions suggest an antigen-driven immune-mediated disease.

Associated Conditions

  • Polymyalgia rheumatica
    • Characterized by stiffness, aching, and pain in the muscles of the neck, shoulders, lower back, hips, and thighs
    • Often occurs in isolation, but may be seen in 40–50% of patients with giant cell arteritis
    • ~10–20% of patients who initially present with features of isolated polymyalgia rheumatica later go on to develop giant cell arteritis.

Giant Cell Arteritis is a sample topic found in
Harrison's Practice.

To find other Harrison's Practice topics
please login or purchase a subscription.

Content Manager
Related Content
The Vasculitis Syndromes
Vascular Diseases of the Extremities

more ...